Paul Ehrlich(redirected from Ehrlich phenomenon)
Also found in: Dictionary, Thesaurus, Medical.
Born Mar. 14, 1854, in Strehlen, Silesia; died Aug. 20, 1915, in Hamburg. German physician, bacteriologist, chemist, and biochemist; founder of chemotherapy.
Ehrlich studied at the universities of Breslau, Strasbourg, and Leipzig. In 1878 he worked as a physician in the Charité Clinic in Berlin.
In 1887 he became a privatdocent and in 1890 an extraordinary professor at the University of Berlin. At the same time, he worked at the Institute for Infectious Diseases, directed by R. Koch. He was appointed director of the Institute for Serum Research in Steglitz in 1896. Beginning in 1899, he was director of the Institute for Experimental Therapy in Frankfurt am Main (the institute now bears his name).
Ehrlich’s main works deal with the biochemistry and chemistry of drugs, experimental pathology and therapy, and immunity. Beginning in 1901, Ehrlich worked on malignant tumors. He described various types of blood leukocytes and demonstrated the role of bone marrow and lymphoid organs in hematopoiesis. He developed methods of treating certain infectious diseases. Ehrlich was the first to show that microorganisms can acquire resistance to drugs. Together with the German scientist A. Bertheim, he developed the drug salvarsan (1907).
Ehrlich was awarded a Nobel Prize in 1908, with E. Metchnikoff.
WORKSThe Collected papers. . ., vols. 1–3. London–New York, 1956–60.
In Russian translation:
Materialy k ucheniiu o khimioterapii. St. Petersburg, 1911.